# Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change

> **NCT01148030** · — · TERMINATED · sponsor: **3M** · enrollment: 333 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** 3M Skin and Nasal Antiseptic

## Key facts

- **NCT ID:** NCT01148030
- **Lead sponsor:** 3M
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 333 (ACTUAL)
- **Why stopped:** Outcome measures for pre-intervention were much lower than anticipated.
- **Last updated:** 2014-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148030, "Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01148030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*